Project Grant R01AG091312
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a Project Grant of $618,410 under the Aging Research program (CFDA 93.866) for the period February 1, 2026 through January 31, 2029. The award funds the development of a deep learning-based miniature microscope designed to advance early detection and understanding of Alzheimer's disease (AD) pathology in preclinical models. The research addresses critical limitations in existing imaging...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a $480,710 Project Grant effective September 5, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). The award supports scientific investigation into a novel vascular signaling pathway that regulates neuronal survival in neurodegenerative diseases, specifically Alzheimer's disease and related dementias (ADRD), amyotrophic lateral sclerosis (ALS), and...
- Grant Summary The National Institute on Aging awarded a $589,154 Project Grant to the University of Maryland, Baltimore, effective February 1, 2026, through January 31, 2031, under the Aging Research program (CFDA 93.866). This award funds the development and validation of a normalized cerebrovascular reactivity (NCVR) magnetic resonance imaging technique to improve detection of vascular contributions to cognitive impairment in patients with small-vessel disease. The research will produce an...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received $1,469,914 in project grant funding from the National Institute on Aging under the Aging Research program (CFDA 93.866) for the period January 1, 2026 through December 31, 2030. The award supports research titled "Probing Mechanistic Links Between Endothelial Aging and Dementia," which develops and applies a novel human induced pluripotent stem cell-endothelial cell (hiPSC-EC) model to investigate the...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University $1,083,046 through the Aging Research program (CFDA 93.866) to develop novel adeno-associated virus (AAV) vectors selectively targeting oligodendrocyte precursor cells (OPCs) and to conduct research on their role in Alzheimer's disease pathology. The two-phase project, initiated August 1, 2025 and concluding July 31, 2027, will generate OPC-selective AAV vectors as tools for in vivo...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded University of Wisconsin-Madison a $640,906 Project Grant effective June 1, 2025, through March 31, 2030, under the Aging Research program (CFDA 93.866). The project delivers advanced neuroimaging research and analysis services focused on elucidating cerebrovascular disease (CVD) pathways to cognitive decline. The primary products include the development and application of a suite of non-invasive vascular neuroimaging tools...
- Federal Grant Award Summary The University of Virginia received a $759,095 Project Grant award from the National Institute on Aging (Aging Research program, CFDA 93.866) on May 15, 2025, with completion targeted for February 28, 2030. The award funds research and development of magnetic resonance (MR) image-guided focused ultrasound (FUS) technology combined with microbubbles to selectively deliver SHIP-1 neutralizing therapies across the blood-brain barrier to brain-resident microglia. The...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a Project Grant totaling $1,308,967 (awarded May 15, 2025, with completion targeted for January 31, 2030) under the Aging Research program (CFDA 93.866) to develop and apply advanced statistical methods for improving scientific inferences in Alzheimer's Disease (AD) research. The project addresses critical methodological gaps in cross-sectional and longitudinal study designs by creating...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $471,885 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective June 1, 2025 through May 31, 2027. This award supports basic biomedical research directed at understanding the mechanisms of brain vascular endothelial cell (BVEC) disruption following vascular brain injury (VBI) and its contribution to vascular cognitive impairment and dementia (VCID). The...
- Federal Grant Award Summary The National Institute on Aging awarded Vasoptic Medical, Inc. a $500,000 Project Grant under the Aging Research program (CFDA 93.866) on September 20, 2025, to develop VasoVue NV, an innovative imaging platform for early detection of Alzheimer's disease through noninvasive assessment of neurovascular reactivity. During Phase I (completion date September 19, 2026), the company will establish proof of concept using animal models by stimulating the mouse retina with...
The Johns Hopkins University received a $465,035 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded February 1, 2026, with completion targeted for January 31, 2031. This award supports the development and clinical validation of a novel non-contrast magnetic resonance imaging (MRI) technique termed Venous Transit Time Imaging by Changes in T1 Relaxation (VICTR) to measure venous transit time (VTT) in the brain. The research addresses a critical gap in understanding vascular cognitive impairment and dementia (VCID), which represents the second leading cause of cognitive dysfunction in older adults. The VICTR technique measures the time required for water molecules to travel from capillary beds to draining cerebral veins by tracking T1 relaxation transitions, providing a non-invasive biomarker for small vessel disease pathology, particularly venous abnormalities associated with white matter hyperintensities. The project will deliver three primary research outcomes: development of the VICTR MRI technique with optimization for clinical application, validation of VTT measurements against established vascular and cognitive markers, and the first clinical application of VTT assessment in VCID populations. Preliminary data demonstrates feasibility and sensitivity of the proposed methodology, with associations observed between VTT and both vascular risk factors and white matter hyperintensities. These deliverables will advance understanding of venous hemodynamics in small vessel disease and establish VTT as a potential diagnostic and monitoring tool for age-related cognitive decline.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $465.0k | 1/20/26 |